Premium
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
Author(s) -
Tulchiner Gennadi,
Brunner Andrea,
Schmidinger Manuela,
Staudacher Nina,
Orme Jacob J.,
Thurnher Martin,
Horninger Wolfgang,
Culig Zoran,
Pichler Renate
Publication year - 2021
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.15341
Subject(s) - nivolumab , medicine , biomarker , immunotherapy , immunohistochemistry , renal cell carcinoma , cancer research , oncology , tumor microenvironment , clinical trial , cancer , biology , biochemistry